ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - bacitracin; neomycin as sulfate; polymyxin b sulfate - משחה לעין - bacitracin 400 u/g; polymyxin b sulfate 5000 u/g; neomycin as sulfate 5 mg/g - antibiotics in combination with other drugs - antibiotics in combination with other drugs - short term treatment of superficial external ocular infections caused by organisms susceptible to one or more of the antibiotics contained therein.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - משחה לעין - aciclovir 3 %w/w - aciclovir - aciclovir - indicated for the treatment of herpes simplex keratitis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - ofloxacin - תמיסה לעין - ofloxacin 0.3 % - ofloxacin - ofloxacin - for the treatment of external ocular infections caused by ofloxacin sensitive organisms.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - prednisolone acetate - תרחיף לעין - prednisolone acetate 1 %w/v - prednisolone - prednisolone - for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - תרחיף לעין - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

ישראל - עברית - Ministry of Health

novartis israel ltd - nepafenac - תרחיף לעין - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

ישראל - עברית - Ministry of Health

novartis israel ltd - dexamethasone; neomycin as sulfate; polymyxin b sulfate - משחה לעין - dexamethasone 1 mg/g; neomycin as sulfate 3500 iu/g; polymyxin b sulfate 6000 iu/g - dexamethasone and antiinfectives - dexamethasone and antiinfectives - for the treatment of eye infections which are responsive to steroids, when an antibiotic is also needed.

ישראל - עברית - Ministry of Health

novartis israel ltd - apraclonidine as hydrochloride - תמיסה לעין - apraclonidine as hydrochloride 5 mg/ml - apraclonidine - apraclonidine - short term adjunctive therapy in patients on maximally tolerated medical therapy who require additional itraocular pressure reduction.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate - תמיסה לעין - brimonidine tartrate 0.15 %w/v - brimonidine - brimonidine - alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.